Lin, Ying-Jen
Ranusch, Allison
Seagull, F. Jacob
Sussman, Jeremy B.
Barnes, Geoffrey D. https://orcid.org/0000-0002-6532-8440
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R18HS026874)
Article History
Received: 27 November 2022
Accepted: 21 June 2023
First Online: 29 June 2023
Declarations
:
: Regulatory approval was obtained from the institutional review board (IRB) at the VA Ann Arbor Healthcare System. Verbal informed consent was obtained from each interview participant.
: Not applicable.
: GDB discloses consulting fees from Pfizer, Bristol-Myers Squibb, Janssen, Bayer, Sanofi, Abbot Vascular, and Boston Scientific and grant funding from Boston Scientific. The other authors declare that they have no competing interests.